Phase I Trial of Haploidentical NK Cells After Pemetrexed in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)

Condition:   Non-small Cell Lung Cancer Intervention:   Biological: Pemetrexed and donor-derived NK cell infusion Sponsors:   Asan Medical Center;   Korea Research Institute of Bioscience and Biotechnology Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials